|
1
|
Roodman GD: Advances in bone biology: the
osteoclast. Endocr Rev. 17:308–332. 1996.PubMed/NCBI
|
|
2
|
Nair SP, Meghji S, Wilson M, Reddi K,
White P and Henderson B: Bacterially induced bone destruction:
mechanisms and misconceptions. Infect Immun. 64:2371–2380.
1996.PubMed/NCBI
|
|
3
|
Orcel P, Feuga M, Bielakoff J and De
Vernejoul MC: Local bone injections of LPS and M-CSF increase bone
resorption by different pathways in vivo in rats. Am J Physiol.
264:E391–E397. 1993.PubMed/NCBI
|
|
4
|
Chiang CY, Kyritsis G, Graves DT and Amar
S: Interleukin-1 and tumor necrosis factor activities partially
account for calvarial bone resorption induced by local injection of
lipopolysaccharide. Infect Immun. 67:4231–4236. 1999.PubMed/NCBI
|
|
5
|
Itoh K, Udagawa N, Kobayashi K, et al:
Lipopolysaccharide promotes the survival of osteoclasts via
Toll-like receptor 4, but cytokine production of osteoclasts in
response to lipopolysaccharide is different from that of
macrophages. J Immunol. 170:3688–3695. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Islam S, Hassan F, Tumurkhuu G, et al:
Bacterial lipopolysaccharide induces osteoclast formation in RAW
264.7 macrophage cells. Biochem Biophys Res Commun. 360:346–351.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mörmann M, Thederan M, Nackchbandi I,
Giese T, Wagner C and Hänsch GM: Lipopolysaccharides (LPS) induce
the differentiation of human monocytes to osteoclasts in a tumour
necrosis factor (TNF) alpha-dependent manner: a link between
infection and pathological bone resorption. Mol Immunol.
45:3330–3337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zou W and Bar-Shavit Z: Dual modulation of
osteoclast differentiation by lipopolysaccharide. J Bone Miner Res.
17:1211–1218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kadono H, Kido J, Kataoka M, Yamauchi N
and Nagata T: Inhibition of osteoblastic cell differentiation by
lipopolysaccharide extract from Porphyromonas gingivalis. Infect
Immun. 67:2841–2846. 1999.PubMed/NCBI
|
|
10
|
Xing Q, Ye Q, Fan M, Zhou Y, Xu Q and
Sandham A: Porphyromonas gingivalis lipopolysaccharide inhibits the
osteoblastic differentiation of prosteoblasts by activating Notch1
signaling. J Cell Physiol. 225:106–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bandow K, Maeda A, Kakimoto K, Kusuyama J,
Shamoto M, Ohnishi T and Matsuguchi T: Molecular mechanisms of the
inhibitory effect of lipopolysaccharide (LPS) on osteoblast
differentiation. Biochem Biophys Res Commun. 402:755–761. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ochi H, Hara Y, Tagawa M, Shinomiya K and
Asou Y: The roles of TNFR1 in lipopolysaccharide-induced bone loss:
dual effects of TNFR1 on bone metabolism via osteoclastogenesis and
osteoblast survival. J Orthop Res. 28:657–663. 2010.
|
|
13
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001.PubMed/NCBI
|
|
14
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sabapathy K, Hochedlinger K, Nam SY, Bauer
A, Karin M and Wagner EF: Distinct roles for JNK1 and JNK2 in
regulating JNK activity and c-Jun-dependent cell proliferation. Mol
Cell. 15:713–725. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Minemoto Y and Lin A: c-Jun
N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for
tumor necrosis factor alpha-induced c-Jun kinase activation and
apoptosis. Mol Cell Biol. 24:10844–10856. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsuguchi T, Chiba N, Bandow K, Kakimoto
K, Masuda A and Ohnishi T: JNK activity is essential for Atf4
expression and late-stage osteoblast differentiation. J Bone Miner
Res. 24:398–410. 2009. View Article : Google Scholar
|
|
19
|
Guo C, Yuan L, Wang JG, et al:
Lipopolysaccharide (LPS) induces the apoptosis and inhibits
osteoblast differentiation through JNK pathway in MC3T3-E1 cells.
Inflammation. 37:621–631. 2014. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Kern B, Shen J, Starbuck M and Karsenty G:
Cbfa1 contributes to the osteoblast-specific expression of type I
collagen genes. J Biol Chem. 276:7101–7107. 2001. View Article : Google Scholar
|
|
22
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, et al: Targeted disruption of Cbfa1 results in
a complete lack of bone formation owing to maturational arrest of
osteoblasts. Cell. 89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HK, Cho SG, Kim JH, Doan TK, Hu QS,
Ulhaq R, et al: Mevinolin enhances osteogenic genes (ALP, type I
collagen and osteocalcin), CD44, CD47 and CD51 expression during
osteogenic differentiation. Life Sci. 84:290–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thunyakitpisal P, Alvarez M, Tokunaga K,
et al: Cloning and functional analysis of a family of nuclear
matrix transcription factors (NP/NMP4) that regulate type I
collagen expression in osteoblasts. J Bone Miner Res. 16:10–23.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakashima K, Zhou X, Kunkel G, Zhang Z,
Deng JM, Behringer RR and de Crombrugghe B: The novel zinc
finger-containing transcription factor osterix is required for
osteoblast differentiation and bone formation. Cell. 108:17–29.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurata H, Guillot PV, Chan J and Fisk NM:
Osterix induces osteogenic gene expression but not differentiation
in primary human fetal mesenchymal stem cells. Tissue Eng.
13:1513–1523. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pearson G, Robinson F, Beers Gibson T, et
al: Mitogen-activated protein (MAP) kinase pathways: regulation and
physiological functions. Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
28
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park GB, Kim YS, Lee HK, Song H, Cho DH,
Lee WJ and Hur DY: Endoplasmic reticulum stress-mediated apoptosis
of EBV-transformed B cells by cross-linking of CD70 is dependent
upon generation of reactive oxygen species and activation of p38
MAPK and JNK pathway. J Immunol. 185:7274–7284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fister S, Günthert AR, Aicher B, Paulini
KW, Emons G and Gründker C: GnRH-II antagonists induce apoptosis in
human endometrial, ovarian, and breast cancer cells via activation
of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Cancer Res. 69:6473–6481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pedram A, Razandi M and Levin ER:
Extracellular signal regulated protein kinase/Jun kinase cross-talk
underlies vascular endothelial cell growth factor-induced
endothelial cell proliferation. J Biol Chem. 273:26722–26728. 1998.
View Article : Google Scholar : PubMed/NCBI
|
